Quality Assessment of the Genetic Test for Familial Hypercholesterolemia in The Netherlands

Introduction. Familial hypercholesterolemia (FH) is an inherited disorder associated with a severely increased risk of cardiovascular disease. Although DNA test results in FH are associated with important medical and ethical consequences, data on accuracy of genetic tests is scarce. Methods. Therefore, we performed a prospective study to assess the overall accuracy of the DNA test used in the genetic cascade screening program for FH in The Netherlands. Individuals aged 18 years and older tested for one of the 5 most prevalent FH mutations, were included consecutively. DNA samples were analyzed by the reference and a counter-expertise laboratory following a standardized procedure. Results. 1003 cases were included. In the end, 317 (32%) carried an FH mutation, whereas in 686 (69%) samples no mutation was found. The overall accuracy of the reference laboratory was 99.8%, with two false positive results identified by the counter-expertise laboratory. Conclusion. The currently used mutation analysis is associated with a very low error rate. Therefore, we do not recommend routine use of duplicate testing.

[1]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[2]  Arthur L. Beaudet,et al.  Which way for genetic-test regulation? Leave test interpretation to specialists , 2010, Nature.

[3]  I. Young,et al.  Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate. , 2005, Atherosclerosis.

[4]  M. Trip,et al.  Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the Netherlands , 2000, Clinical genetics.

[5]  M. Trip,et al.  Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. , 2006, European Heart Journal.

[6]  E. Levy,et al.  Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. , 1995, Pediatrics.

[7]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[8]  J. Kastelein,et al.  Molecular Basis of Autosomal Dominant Hypercholesterolemia: Assessment in a Large Cohort of Hypercholesterolemic Children , 2011, Circulation.

[9]  E. Sijbrands,et al.  Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal , 2010, PloS one.

[10]  William,et al.  The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00) , 2004, Biochemistry (Moscow).

[11]  A. Gotto,et al.  Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. , 1984, Circulation.

[12]  J. Kastelein,et al.  Update of the molecular basis of familial hypercholesterolemia in The Netherlands , 2005, Human mutation.

[13]  J. Kastelein,et al.  Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[14]  J. Kastelein,et al.  Familial hypercholesterolemia: current treatment and advances in management , 2008, Expert review of cardiovascular therapy.

[15]  S E Humphries,et al.  Update and Analysis of the University College London Low Density Lipoprotein Receptor Familial Hypercholesterolemia Database , 2008, Annals of human genetics.

[16]  I. Fokkema,et al.  LOVD: Easy creation of a locus‐specific sequence variation database using an “LSDB‐in‐a‐box” approach , 2005, Human mutation.

[17]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[18]  Bin Chen,et al.  Good laboratory practices for molecular genetic testing for heritable diseases and conditions. , 2009 .

[19]  E. Ros,et al.  The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia. , 2002, Atherosclerosis.

[20]  E. Sijbrands,et al.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.

[21]  J. Kastelein,et al.  Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants. , 2012, European heart journal.

[22]  R. Sy,et al.  Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. , 2005, Journal of atherosclerosis and thrombosis.

[23]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[24]  O. Faergeman,et al.  The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. , 2005, Atherosclerosis.

[25]  J. Lindemans,et al.  Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood. , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[26]  J. Kastelein,et al.  Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study , 2012, European Journal of Human Genetics.

[27]  M. Durán,et al.  Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis , 2012, Clinical genetics.

[28]  Roger I Glass,et al.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  S. Antonarakis,et al.  Corrigendum: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2002, Human mutation.

[30]  J. Kastelein,et al.  Functionality of sequence variants in the genes coding for the low‐density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia , 2010, Human mutation.

[31]  A. Montali,et al.  Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. , 2008, Atherosclerosis.

[32]  Sonia Shah,et al.  Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study , 2013, The Lancet.